A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Clinical trial NCT06859268 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06859268
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2028-04-01
- Enrollment
- 643
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.